Unraveling One-Carbon Metabolism in Metabolic Dysfunction-Associated Steatotic Liver Disease: Semaglutide Turns Metabolic Stress Into Metabolic Resilience
DOI:
https://doi.org/10.14740/cmmr107Abstract
N/A
Published
2025-12-24
Issue
Section
Letter to the Editor
License
Copyright (c) 2025 The authors

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Lonardo A, Weiskirchen R. Unraveling One-Carbon Metabolism in Metabolic Dysfunction-Associated Steatotic Liver Disease: Semaglutide Turns Metabolic Stress Into Metabolic Resilience. Cell Mol Med Res. 2025;3(2):35-39. doi:10.14740/cmmr107







